Literature DB >> 17276953

Holter monitoring for 24 hours in patients with thromboembolic stroke and sinus rhythm diagnosed in the emergency department.

Muge Gunalp1, Enver Atalar, Figen Coskun, Arda Yilmaz, Serdar Aksoyek, Nalan Metin Aksu, Bulent Sivri.   

Abstract

It is well known that patients with ischemic stroke show ST-T abnormalities and various rhythm abnormalities on an electrocardiogram (ECG). The most commonly encountered rhythm abnormality is atrial fibrillation. It was recently shown that paroxysmal atrial fibrillation (PAF) is an important causative factor in patients with stroke. Detection of PAF is important in identifying the cause, prognosis, and treatment in patients with thromboembolic stroke. Investigators in the present study followed patients with thromboembolic stroke who had been admitted to the emergency department in sinus rhythm; 24-h Holter monitoring was used, and patients were assessed at referral and every 6 h for 24 h with ECG, which was used to detect rhythm disturbances, especially PAF. In 26 patients with stroke who came to the emergency department, acute thromboembolic stroke was diagnosed on the basis of magnetic resonance imaging; no rhythm abnormalities were noted on Holter monitoring. Eighteen patients were male and 8 were female (mean age: 66+/-13 y). Arrhythmia was identified on ECG in 3 patients (11%) and on 24-h Holter monitoring in 24 patients (92%). PAF was diagnosed in 3 patients (11%) on ECG and in 11 patients (42%) on Holter monitoring. In 2 patients, nonsustained ventricular tachycardia was detected only on Holter monitoring, which was found to be significantly superior to ECG for the detection of arrhythmias (P<.001). Investigators found no significant relationship between PAF and variables such as hypertension, diabetes, coronary artery disease, history of myocardial infarction, ST-T changes, and elevations in cardiac markers. However, a significant relationship (P<.01) was seen between nonsustained ventricular tachycardia and a history of myocardial infarction. No relationship was discerned between arrhythmia and stroke localization. Study results suggested that (1) PAF is a commonly diagnosed rhythm abnormality, and (2) Holter monitoring is superior to routine ECG for the detection of arrhythmias such as PAF in patients anticipated to have thromboembolic stroke with sinus rhythm.

Entities:  

Mesh:

Year:  2006        PMID: 17276953     DOI: 10.1007/bf02850206

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  6 in total

1.  [European Stroke Organisation 2008 guidelines for managing acute cerebral infarction or transient ischemic attack. Part 1].

Authors:  P Ringleb; P D Schellinger; W Hacke
Journal:  Nervenarzt       Date:  2008-08       Impact factor: 1.214

2.  The Evolution and Application of Cardiac Monitoring for Occult Atrial Fibrillation in Cryptogenic Stroke and TIA.

Authors:  Daniel J Miller; Kavit Shah; Sumul Modi; Abhimanyu Mahajan; Salman Zahoor; Muhammad Affan
Journal:  Curr Treat Options Neurol       Date:  2016-04       Impact factor: 3.598

Review 3.  [Stroke and atrial fibrillation].

Authors:  G Gahn
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-06

Review 4.  Detection of occult atrial fibrillation in patients with embolic stroke of uncertain source: a work in progress.

Authors:  Jason G Andrade; Thalia Field; Paul Khairy
Journal:  Front Physiol       Date:  2015-04-01       Impact factor: 4.566

5.  [Contribution of Holter ECG in the etiologic diagnosis of the ischemic stroke in Brazzaville, Congo].

Authors:  Stéphane Méo Ikama; Jospin Makani; Ghislain Mpandzou; Paul Macaire Ossou-Nguiet; Bernice Mesmer Nsitou; Munka Nkalla Lambi; Edgard Matali; Thierry Raoul Gombet; Suzy Gisèle Kimbally Kaky
Journal:  Pan Afr Med J       Date:  2018-12-19

6.  Atrial fibrillation detection using single lead portable electrocardiographic monitoring: a systematic review and meta-analysis.

Authors:  Satish Ramkumar; Nitesh Nerlekar; Daniel D'Souza; Derek J Pol; Jonathan M Kalman; Thomas H Marwick
Journal:  BMJ Open       Date:  2018-09-17       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.